Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Diabetic Macular Edema (DME) is a leading cause of blindness among the working age population in most developed countries. DME is one of the major complications of diabetes and DME patients utilise significantly higher healthcare resources than non-DME diabetic patients.
The report details the trend, potential and market size of Diabetic Macular Edema Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Diabetic Macular Edema Drugmarket, defines the market attractiveness level of Diabetic Macular Edema Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Diabetic Macular Edema Drug industry, describes the types of Diabetic Macular Edema Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Diabetic Macular Edema Drug market and the development prospects and opportunities of Diabetic Macular Edema Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Diabetic Macular Edema Drug market in Chapter 13.
By Player:
Alimera
Hoffman-La Roche
Bayer
Allergan
Valeant
Novartis
By Type:
Intravitreal Injections
Intravitreal Implants
By End-User:
Anti-VEGF
Corticosteroids
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Diabetic Macular Edema Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Diabetic Macular Edema Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Diabetic Macular Edema Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Diabetic Macular Edema Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Diabetic Macular Edema Drug Market Analysis and Outlook to 2022
-
7.1 Global Diabetic Macular Edema Drug Consumption (2017-2022)
-
7.2 United States Diabetic Macular Edema Drug Consumption (2017-2022)
-
7.3 Europe Diabetic Macular Edema Drug Consumption (2017-2022)
-
7.4 China Diabetic Macular Edema Drug Consumption (2017-2022)
-
7.5 Japan Diabetic Macular Edema Drug Consumption (2017-2022)
-
7.6 India Diabetic Macular Edema Drug Consumption (2017-2022)
-
7.7 South Korea Diabetic Macular Edema Drug Consumption (2017-2022)
8 Region and Country-wise Diabetic Macular Edema Drug Market Analysis and Outlook to 2028
-
8.1 Global Diabetic Macular Edema Drug Consumption Forecast (2022-2028)
-
8.2 United States Diabetic Macular Edema Drug Consumption Forecast (2022-2028)
-
8.3 Europe Diabetic Macular Edema Drug Consumption Forecast (2022-2028)
-
8.4 China Diabetic Macular Edema Drug Consumption Forecast (2022-2028)
-
8.5 Japan Diabetic Macular Edema Drug Consumption Forecast (2022-2028)
-
8.6 India Diabetic Macular Edema Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Diabetic Macular Edema Drug Consumption Forecast (2022-2028)
9 Global Diabetic Macular Edema Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Diabetic Macular Edema Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Intravitreal Injections Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Intravitreal Implants Consumption and Growth Rate (2017-2022)
-
9.2 Global Diabetic Macular Edema Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Anti-VEGF Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Diabetic Macular Edema Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Diabetic Macular Edema Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Intravitreal Injections Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Intravitreal Implants Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Diabetic Macular Edema Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Anti-VEGF Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Diabetic Macular Edema Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Diabetic Macular Edema Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Diabetic Macular Edema Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Diabetic Macular Edema Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Diabetic Macular Edema Drug Market Competitive Analysis
-
14.1 Alimera
-
14.1.1 Alimera Company Details
-
14.1.2 Alimera Diabetic Macular Edema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Alimera Diabetic Macular Edema Drug Product and Service
-
14.2 Hoffman-La Roche
-
14.2.1 Hoffman-La Roche Company Details
-
14.2.2 Hoffman-La Roche Diabetic Macular Edema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Hoffman-La Roche Diabetic Macular Edema Drug Product and Service
-
14.3 Bayer
-
14.3.1 Bayer Company Details
-
14.3.2 Bayer Diabetic Macular Edema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer Diabetic Macular Edema Drug Product and Service
-
14.4 Allergan
-
14.4.1 Allergan Company Details
-
14.4.2 Allergan Diabetic Macular Edema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Allergan Diabetic Macular Edema Drug Product and Service
-
14.5 Valeant
-
14.5.1 Valeant Company Details
-
14.5.2 Valeant Diabetic Macular Edema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Valeant Diabetic Macular Edema Drug Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Diabetic Macular Edema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Diabetic Macular Edema Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Diabetic Macular Edema Drug
-
Figure Diabetic Macular Edema Drug Picture
-
Table Global Diabetic Macular Edema Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Diabetic Macular Edema Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Diabetic Macular Edema Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Diabetic Macular Edema Drug Consumption by Country (2017-2022)
-
Figure United States Diabetic Macular Edema Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Diabetic Macular Edema Drug Consumption and Growth Rate (2017-2022)
-
Figure China Diabetic Macular Edema Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Diabetic Macular Edema Drug Consumption and Growth Rate (2017-2022)
-
Figure India Diabetic Macular Edema Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Diabetic Macular Edema Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetic Macular Edema Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Diabetic Macular Edema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Diabetic Macular Edema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Diabetic Macular Edema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Diabetic Macular Edema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Diabetic Macular Edema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Diabetic Macular Edema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravitreal Injections Consumption and Growth Rate (2017-2022)
-
Figure Global Intravitreal Implants Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-VEGF Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Intravitreal Injections Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravitreal Implants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-VEGF Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Diabetic Macular Edema Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Diabetic Macular Edema Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Alimera (Foundation Year, Company Profile and etc.)
-
Table Alimera Diabetic Macular Edema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alimera Diabetic Macular Edema Drug Product and Service
-
Table Hoffman-La Roche (Foundation Year, Company Profile and etc.)
-
Table Hoffman-La Roche Diabetic Macular Edema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffman-La Roche Diabetic Macular Edema Drug Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Diabetic Macular Edema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Diabetic Macular Edema Drug Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Diabetic Macular Edema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Diabetic Macular Edema Drug Product and Service
-
Table Valeant (Foundation Year, Company Profile and etc.)
-
Table Valeant Diabetic Macular Edema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Diabetic Macular Edema Drug Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Diabetic Macular Edema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Diabetic Macular Edema Drug Product and Service
-
